Results 111 to 120 of about 16,071 (223)

Organelle resolved proteomics uncovers PLA2R1 as a novel cell surface marker required for chordoma growth

Acta Neuropathologica Communications
Chordomas are clinically aggressive tumors with a high rate of disease progression despite maximal therapy. Given the limited therapeutic options available, there remains an urgent need for the development of novel therapies to improve clinical outcomes.
Shahbaz Khan, Jeffrey A. Zuccato, Vladimir Ignatchenko, Olivia Singh, Meinusha Govindarajan, Matthew Waas, Salvador Mejia-Guerrero, Andrew Gao, Gelareh Zadeh, Thomas Kislinger   +9 more
doaj   +1 more source

Chordoma [PDF]

Acta Neurochirurgica, 2017
openaire   +2 more sources

Chordoma [PDF]

Ear, Nose & Throat Journal, 2011
openaire   +2 more sources

Identification of immune subtypes associated with the prognosis in skull base chordoma

Acta Neuropathologica Communications
Chordoma is a rare malignant bone tumor that is prone to local recurrence. Recent omics studies suggest that chordoma is a heterogenous disease and the tumor immune microenvironment (TIME) may be associated with chordoma recurrence and patient survival ...
Yujia Xiong, Mingxuan Li, Guangyi Niu, Tianyi Xu, Chuzhong Li, Tianshun Ma, Tianhao Zhang, Hela Koka, Lili Hao, Yazhuo Zhang, Jiwei Bai, Xiaohong R. Yang   +11 more
doaj   +1 more source

Chordoma [PDF]

Proceedings of the Royal Society of Medicine, 1962
openaire   +2 more sources

SACRAL CHORDOMA

Annals of Surgery, 1931
J A, Dickson, C A, Lamb
openaire   +3 more sources

The copy-number events in skull base chordoma stratify tumours into four biologically coherent groups. [PDF]

Neoplasia
Baluszek S, Kober P, Woroniecka R, Maławska N, Wągrodzki M, Kunicki J, Mandat T, Grygalewicz B, Bujko M.   +8 more
europepmc   +1 more source

Artificial intelligence chatbots in response to patient's common inquiries about chordoma: A cross-sectional study. [PDF]

Brain Spine
He S, Jiang D, Jiang R, Yin M, Yu S, Jiang X, Zhou L, Zhou Z, Wei H, Xiao J.   +9 more
europepmc   +1 more source

Incidence patterns and trends of chordoma in the United States: a population-based analysis of over 6,000 cases. [PDF]

J Bone Oncol
Sung H, Jiang C, Koka H, Bai J, Goldstein AM, Yang XR.   +5 more
europepmc   +1 more source

A patient-derived organoid model identifies TP53-dependent gemcitabine sensitivity in spinal chordoma. [PDF]

Discov Oncol
Hu P, Zeng S, Lei J, Zhou H, Wang B, Liu Z, Liu X, Wei F.   +7 more
europepmc   +1 more source